These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

169 related items for PubMed ID: 21871156

  • 21. Fluoxetine pretreatment effects pharmacokinetics of 3,4-methylenedioxymethamphetamine (MDMA, ECSTASY) in rat.
    Upreti VV, Eddington ND.
    J Pharm Sci; 2008 Apr; 97(4):1593-605. PubMed ID: 17724664
    [Abstract] [Full Text] [Related]

  • 22. Disposition of methylenedioxymethamphetamine and three metabolites in the brains of different rat strains and their possible roles in acute serotonin depletion.
    Chu T, Kumagai Y, DiStefano EW, Cho AK.
    Biochem Pharmacol; 1996 Mar 22; 51(6):789-96. PubMed ID: 8602874
    [Abstract] [Full Text] [Related]

  • 23. Direct comparison of (+/-) 3,4-methylenedioxymethamphetamine ("ecstasy") disposition and metabolism in squirrel monkeys and humans.
    Mueller M, Kolbrich EA, Peters FT, Maurer HH, McCann UD, Huestis MA, Ricaurte GA.
    Ther Drug Monit; 2009 Jun 22; 31(3):367-73. PubMed ID: 19417716
    [Abstract] [Full Text] [Related]

  • 24. Distribution of 3,4-methylenedioxymethamphetamine (MDMA) and 3,4-methylenedioxyamphetamine (MDA) stereoisomers in a fatal poisoning.
    Moore KA, Mozayani A, Fierro MF, Poklis A.
    Forensic Sci Int; 1996 Dec 02; 83(2):111-9. PubMed ID: 9022274
    [Abstract] [Full Text] [Related]

  • 25. Population pharmacokinetics of 3,4-methylenedioxymethamphetamine and main metabolites in rats.
    Hirt D, Fonsart J, Menet MC, Debray M, Noble F, Declèves X, Scherrmann JM.
    Toxicol Sci; 2010 Mar 02; 114(1):38-47. PubMed ID: 20008456
    [Abstract] [Full Text] [Related]

  • 26. Development and validation of an LC-MS/MS method after chiral derivatization for the simultaneous stereoselective determination of methylenedioxy-methamphetamine (MDMA) and its phase I and II metabolites in human blood plasma.
    Steuer AE, Schmidhauser C, Liechti ME, Kraemer T.
    Drug Test Anal; 2015 Jul 02; 7(7):592-602. PubMed ID: 25371386
    [Abstract] [Full Text] [Related]

  • 27. Dopamine D2-receptor knockout mice are protected against dopaminergic neurotoxicity induced by methamphetamine or MDMA.
    Granado N, Ares-Santos S, Oliva I, O'Shea E, Martin ED, Colado MI, Moratalla R.
    Neurobiol Dis; 2011 Jun 02; 42(3):391-403. PubMed ID: 21303698
    [Abstract] [Full Text] [Related]

  • 28. Dopamine transporter down-regulation following repeated cocaine: implications for 3,4-methylenedioxymethamphetamine-induced acute effects and long-term neurotoxicity in mice.
    Peraile I, Torres E, Mayado A, Izco M, Lopez-Jimenez A, Lopez-Moreno JA, Colado MI, O'Shea E.
    Br J Pharmacol; 2010 Jan 02; 159(1):201-11. PubMed ID: 20015297
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Usefulness of saliva for measurement of 3,4-methylenedioxymethamphetamine and its metabolites: correlation with plasma drug concentrations and effect of salivary pH.
    Navarro M, Pichini S, Farré M, Ortuño J, Roset PN, Segura J, de la Torre R.
    Clin Chem; 2001 Oct 02; 47(10):1788-95. PubMed ID: 11568088
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Enantioselective metabolism of the designer drugs 3,4-methylenedioxymethamphetamine ('ecstasy') and 3,4-methylenedioxyethylamphetamine ('eve') isomers in rat brain and blood.
    Meyer A, Mayerhofer A, Kovar KA, Schmidt WJ.
    Neurosci Lett; 2002 Sep 20; 330(2):193-7. PubMed ID: 12231444
    [Abstract] [Full Text] [Related]

  • 33. Stereospecific analysis and enantiomeric disposition of 3, 4-methylenedioxymethamphetamine (Ecstasy) in humans.
    Fallon JK, Kicman AT, Henry JA, Milligan PJ, Cowan DA, Hutt AJ.
    Clin Chem; 1999 Jul 20; 45(7):1058-69. PubMed ID: 10388483
    [Abstract] [Full Text] [Related]

  • 34. Non-linear pharmacokinetics of MDMA ('ecstasy') in humans.
    de la Torre R, Farré M, Ortuño J, Mas M, Brenneisen R, Roset PN, Segura J, Camí J.
    Br J Clin Pharmacol; 2000 Feb 20; 49(2):104-9. PubMed ID: 10671903
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. The effect of caffeine on MDMA-induced hydroxyl radical production in the mouse striatum.
    Górska AM, Noworyta-Sokołowska K, Gołembiowska K.
    Pharmacol Rep; 2014 Aug 20; 66(4):718-21. PubMed ID: 24948078
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. The hyperthermic and neurotoxic effects of 'Ecstasy' (MDMA) and 3,4 methylenedioxyamphetamine (MDA) in the Dark Agouti (DA) rat, a model of the CYP2D6 poor metabolizer phenotype.
    Colado MI, Williams JL, Green AR.
    Br J Pharmacol; 1995 Aug 20; 115(7):1281-9. PubMed ID: 7582557
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.